title: Current standards of care in bladder and prostate rhabdomyosarcoma.
abstract: Rhabdomyosarcoma (RMS) is the most common soft tissue tumor in children, and 15% to 20% arise from the genitourinary tract. Multicenter collaborative studies have improved survival substantially, and in addition to excellent oncologic control, current treatment focuses on organ preservation and minimization of late treatment effects. The multiple modalities needed to treat RMS dictate that treating physicians must be familiar with the disease as well as the goals and possible sequelae of treatment with chemotherapy, radiotherapy, and surgery. This article discusses the current standards of care for bladder and prostate RMS.
authors.forename: Kathleen
authors.initials: K
authors.lastname: Kieran
authors.forename: Margarett
authors.initials: M
authors.lastname: Shnorhavorian
mesh_terms: D002648:Child; D002675:Child, Preschool; D006801:Humans; D008297:Male; D011467:Prostate / Q000473:pathology; D011471:Prostatic Neoplasms / Q000473:pathology / Q000628:therapy*; D012208:Rhabdomyosarcoma / Q000473:pathology / Q000628:therapy*; D001743:Urinary Bladder / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000473:pathology / Q000628:therapy*